Women on oral hormonal therapy for menorrhagia are at risk of cerebral venous thrombosis (CVT). This condition is charac terized by intravascular clotting in the venous system of brain. In this case which is being presented for its rarity, the patient developed CVT following use of low dose estrogen proges terone combination pill; hence, treatment was stopped. Withdrawal of oral contraceptive pill (OCP) was associated with profuse vaginal bleed. Emergency hysterectomy was risky as patient was unstable. Levonorgestrel intrauterine system (LNGIUS) proved to be a safe effective innovative option in this situation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.